

Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
The challenges of poor water solubility in newly developed medicinal chemical entities and the role of solid dispersions as an intermediate in pharmaceutical preparations. The document also provides information on the services offered by cd formulation for customizing solid dispersion carriers and preparation methods.
Typology: Study notes
1 / 3
This page cannot be seen from the preview
Don't miss anything!
About 40% of newly developed medicinal chemical entities have poor water solubility, and 90% of drugs under development can be classified as poorly soluble drugs. In response to this problem, synthetic chemists have made salts with weak bases or weak acids and poorly soluble drugs, but in fact only 20% ~ 30% of new chemical entities are easy to form salts, and the remaining 70% ~ 80% of new chemical entities. A solid dispersion (SD) refers to a dispersion system in which the drug particle size is within the range of 0.001 to 0.1 μm in a certain state and uniformly dispersed in a solid carrier. As an intermediate of pharmaceutical preparations, solid dispersions can increase the dissolution of poorly soluble drugs, improve bioavailability, delay drug release, increase drug stability, and solidify liquid drugs. Fig.1 Schematic diagram of solid dispersion formation
As a supplier of pharmaceutical preparations, CD Formulation has pharmacy and other professional researchers and experimenters, and has extensive experience in drug development. Our company can customize the carrier
material of the solid dispersion for the customer, and provide corresponding product solutions to facilitate the commercialization of the customer's drug. The carrier services we can currently customize for customers include the following: